Related Experiment Video
Updated: Mar 29, 2026

Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia
Published on: July 2, 2013
Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis
Eloi Magnin1, Yoshimasa Sagawa, Ludivine Chamard
1Regional Memory Centre (CMRR), Department of Neurology, University Hospital of Besanx00E7;on, Besanx00E7;on, France.
Background/Aims:
Fampridine is sometimes reported to improve cognition and especially the information-processing speed. Motor improvement might be a confounding factor. The aim of this study was to evaluate the effects of fampridine on verbal fluencies in patients with multiple sclerosis (MS).
Methods:
Fifty MS patients were included in a prospective monocentric open label trial with a mean Expanded Disability Status Scale of 5.3 ± 1.1. Assessments of verbal phonological and semantic fluencies were repeated twice (within 1 week) before fampridine treatment and twice after fampridine treatment in order to have the maximal practice effect. Gait velocity and fatigue (visual analogical scale) were also assessed. Distribution into gait responders, gait non-responders, fluency responders and fluency non-responders, was described.
Results:
Verbal fluencies were significantly higher after fampridine treatment. No correlation was observed between phonological fluency improvement and semantic fluency improvement. Gait responders and gait non-responders did not present significant differences in verbal fluency performance and fatigue score. No correlation between gait velocity improvement and fatigue improvement compared with verbal fluency improvement was observed.
Conclusion:
Our results suggest that fampridine could have a selective procognitive effect on phonological fluency in MS, even in the gait non-responder patients.
Insights
Fampridine may enhance cognitive processing in multiple sclerosis (MS) patients, particularly improving phonological fluency. This effect appears selective and independent of motor improvements in gait.
Area of Science:
- Neuroscience
- Clinical Neurology
- Pharmacology
Background:
- Fampridine is investigated for cognitive benefits in multiple sclerosis (MS).
- Motor improvements may confound cognitive assessments.
- The study aims to isolate fampridine's effects on verbal fluency in MS.
Purpose of the Study:
- To evaluate the impact of fampridine on verbal phonological and semantic fluencies in MS patients.
- To determine if fampridine has a selective effect on cognition, independent of motor function.
Main Methods:
- Prospective, open-label trial with 50 MS patients (EDSS 5.3 ± 1.1).
- Verbal fluency (phonological and semantic) assessed twice before and twice after fampridine treatment.
- Gait velocity and fatigue also measured to assess potential confounding factors.
Main Results:
- Significant improvements in verbal fluencies observed post-fampridine treatment.
- No correlation found between phonological and semantic fluency improvements.
- No significant differences in verbal fluency or fatigue between gait responders and non-responders.
Conclusions:
- Fampridine may offer a selective procognitive benefit, specifically on phonological fluency in MS.
- This cognitive effect is apparent even in patients who do not show gait improvement.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Parkinson's Disease: Overview
Inhibitors of Viral Protein Synthesis

